Lynx Capital Group’s iShares US Medical Devices ETF IHI Stock Holding History

Lynx Capital Group’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.21M	Buy	125,665 +23,731	+23%	+$1.2M	2.51%	9
2026 Q1	$5.44M	Sell	101,934 -589	-0.6%	-$34.6K	2.53%	9
2025 Q4	$6.37M	Buy	102,523 +257	+0.3%	+$15.9K	2.92%	7
2025 Q3	$6.14M	Buy	102,266 +1,090	+1%	+$66.7K	2.85%	8
2025 Q2	$6.34M	Sell	101,176 -914	-0.9%	-$54.9K	3.06%	5
2025 Q1	$6.14M	Buy	102,090 +20,406	+25%	+$1.27M	3.16%	7
2024 Q4	$4.77M	Buy	81,684 +13,891	+20%	+$826K	2.74%	10
2024 Q3	$4.01M	Buy	67,793 +1,595	+2%	+$91.1K	2.6%	10
2024 Q2	$3.71M	Buy	66,198 +1,010	+2%	+$56.5K	2.57%	9
2024 Q1	$3.82M	Buy	65,188 +9,194	+16%	+$519K	2.58%	10
2023 Q4	$3.02M	Buy	+55,994	New	+$2.74M	2.2%	11

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lynx Capital Group's IHI Position: Q2 2026 in Review

Lynx Capital Group increased its iShares US Medical Devices ETF (IHI) stake by 23% in Q2 2026, buying an estimated $1.2M and bringing the position to 125,665 shares worth $6.21M. The position accounts for 2.51% of the portfolio, ranked #9.

Lynx Capital Group first reported a position in IHI in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.37M in Q4 2025. 475 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Lynx Capital Group held 125,665 shares of iShares US Medical Devices ETF worth $6.21M as of Q2 2026.
Lynx Capital Group bought 23,731 iShares US Medical Devices ETF shares in Q2 2026, an estimated $1.2M.
iShares US Medical Devices ETF made up 2.51% of Lynx Capital Group's portfolio in Q2 2026, its #9 holding.
Lynx Capital Group first reported a position in iShares US Medical Devices ETF in Q4 2023 and has held it in 11 quarters since.
Lynx Capital Group's iShares US Medical Devices ETF position peaked at $6.37M in Q4 2025.
475 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Lynx Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.